Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
LumiThera, Inc. Selected to Present at the Ophthalmology Innovation Summit 2018 at the American Academy of Ophthalmology, Chicago, IL | ||
By: PR Newswire Association LLC. - 20 Oct 2018 | Back to overview list |
|
SEATTLE, Oct. 19, 2018 /CNW/ -- LumiThera® Inc., a commercial-stage medical device company focused on developing photobiomodulation (PBM) therapies for ocular disorders and disease, today announced that it will present at the Ophthalmology Innovation Summit at the American Academy of Ophthalmology (OIS@AAO) meeting on October 25, 2018, in Chicago, IL. OIS unites industry, entrepreneurial and clinical leaders to collaborate on the development and commercialization of innovative drugs and devices to address unmet clinical needs. "We welcome the opportunity to present our company and our vision with other leaders in the ophthalmic industry at the OIS," said Clark Tedford, Ph.D., President and CEO of LumiThera. Dr. Tedford's talk will highlight results from LumiThera's LIGHTSITE I Study and provide an update on the development of the Valeda® Light Delivery System, which is being studied for the treatment of dry Age-related Macular Degeneration. Details of the presentations are as follows: Meeting: OIS@AAO About LumiThera, Inc. The Valeda Light Delivery System has been granted authorization to use the CE Mark by an EU Notified Body as required for commercial use in the European Union only. Valeda™ is not approved for use by the Food & Drug Administration (FDA) in the USA. 2018 LumiThera, Inc., All rights reserved.
View original content to download multimedia:http://www.prnewswire.com/news-releases/lumithera-inc-selected-to-present-at-the-ophthalmology-innovation-summit-2018-at-the-american-academy-of-ophthalmology-chicago-il-300734642.html SOURCE LumiThera, Inc. |
||
|
||
Copyright 2018 PR Newswire Association LLC. | Back to overview list |